CellCentric vs Gossamer Bio

CellCentric vs Gossamer Bio, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Gossamer Bio on 54/100.

CellCentric logo
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Try CellCentric
Gossamer Bio logo
Gossamer BioA biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
Try Gossamer Bio

Where each one leads

CellCentric

  • our overall score: 60/100 against 54/100
  • funding raised: $375M against $150M
  • LinkedIn following: 28,695 against 14,489

Gossamer Bio

  • agent readiness: 47/100 against 32/100
  • domain rating: 49/100 against 35/100
  • headcount: 154 against 53

At a glance

MeasureCellCentricGossamer Bio
What it isA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Pharmaceuticals, Healthcare, Biotech
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20032017
HeadquartersCambridge, United KingdomSan Diego, USA
StatusActiveActive

Size, funding and growth

MeasureCellCentricGossamer Bio
Employees53154
Total funding$375M$150M
Latest roundSeries DSeries B
ValuationNot published$1.1B
LinkedIn followers28,69514,489

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellCentricGossamer Bio
StartupHub scoreOur 0-100 rating60/10054/100
Traction57/10060/100
Team60/100Not published
Search visibility44/10030/100
Quality68/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)D (47/100)
Domain ratingLink authority, 0-10035/10049/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellCentricGossamer Bio
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4Google Tag Manager

CellCentric vs Gossamer Bio: common questions

Which is better, CellCentric or Gossamer Bio?

On our 0-100 score CellCentric rates higher (60/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do CellCentric and Gossamer Bio compare on the numbers?

CellCentric leads on our overall score (60/100 against 54/100), funding raised ($375M against $150M), LinkedIn following (28,695 against 14,489). Gossamer Bio leads on agent readiness (47/100 against 32/100), domain rating (49/100 against 35/100), headcount (154 against 53).

Read the full CellCentric review and pricing or the Gossamer Bio review and pricing. You can also browse other CellCentric alternatives we track.